Anti-Inflammatory Effect of Centella asiatica Extract on Prevented Aortic Intima-Media Thickening in Diabetic Rats

Amalia Anita Hawas, Dwi Aris Agung Nugrahaningsih, Eti Nurwening Sholikhah, Sadli Syarifuddin, Rahmi Ayu Wijayaningsih, Ngatidjan Ngatidjan

Abstract


Objectives: To explore the effect of C. asiatica extract on intima-media thickness, eNOS expression, and macrophage M1/M2 ratio in diabetic rats aorta. Materials and Methods: Wistar rats consisted of normal group and diabetic group which divided into negative control, positive control (captopril 50 mg/kg/day), C. asiatica extract (dose  250, 500, and 1000 mg/kg/day). The aorta was harvested after treatment for 8 weeks to measure intima-media thickness, eNOS mRNA expression, and macrophage M1/M2 ratio. Results: Dose 500 and 1000 mg/kg/day C. asiatica extract prevent aortic intima-media thickening (p < 0.05). Then dose of 1000 mg/kg/day prevent the increase of M1/M2 ratio (p < 0.05). Expression of eNOS mRNA did not give any significant results (p > 0.05). Conclusion: The extract of C. asiatica has anti-inflammatory effect and ability to prevent intima-media thickening on diabetic rats aorta.

 

Key words: Centella asiatica extract, Aortic Intima-Media Thickness, eNOS mRNA Expression, Macrophage Polarization, Diabetes Mellitus


Full Text:

51-57;PDF

References


Peiró C, Romacho T, Azcutia V, et al. Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway. Cardiovasc Diabetol 2016;15:1-15.

Britton KA and Fox CS. Perivascular adipose tissue and vascular disease. Clin Lipidol 2011;6:79-9.

Aghamohammadzadeh R, Withers S, Lynch F, Greenstein A, Malik R, and Heagerty A. Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target: Signals from PVAT. Br J Pharmacol 2012;165:670–82.

Omar A, Chatterjee TK, Tang Y, Hui DY, and Weintraub NL. Proinflammatory phenotype of perivascular adipocytes. Arterioscler Thromb Vasc Biol 2014;34:1631–6.

Payne GA, Kohr MC, and Tune JD. Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease. Br J Pharmacol 2012;165:659–69.

Lastra G and Manrique C. Perivascular adipose tissue, inflammation and insulin resistance: link to vascular dysfunction and cardiovascular disease. Horm Mol Biol Clin Investig 2015;22:19-26.

Gawaz M, Brand K, Dickfeld T, et al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 2000;148:75–85.

Siracuse JJ and Chaikof EL. The Pathogenesis of Diabetic Atherosclerosis. In: Shrikhande GV, McKinsey JF, editors. Diabetes and Peripheral Vascular Disease. Totowa, NJ: Humana Press 2012;13–26.

Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones 2007;39:86–93.

Underwood PC and Adler GK. The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans. Curr Hypertens Rep 2013;15:59–70.

Yagil Y and Yagil C. Hypothesis: ACE2 Modulates Blood Pressure in the Mammalian Organism. Hypertension 2003;41:871–3.

Giacchetti G, Sechi LA, Rilli S, and Carey RM. The renin–angiotensin–aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab 2005;16:120–6.

Jamil S, Nizami Q, and Salam M. Centella asiatica (Linn.) Urban: A review. Natural Product Radiance 2007;6:158–170.

Maulidiani, Abas F, Khatib A, et al. Metabolic alteration in obese diabetes rats upon treatment with Centella asiatica extract. J Ethnopharmacol 2016;180:60–9.

Loh SP and Hadira O. 2011. In vitro inhibitory potential of selected Malaysian plants against key enzymes involved in hyperglycemia and hypertension. Malays J Nutr 2011;17:77–86.

Alqahtani A, Hamid K, Kam A, et al. The pentacyclic triterpenoids in herbal medicines and their pharmacological activities in diabetes and diabetic complications. Curr Med Chem 2013;20:908–31.

Kempler P. Learning from large cardiovascular clinical trials: Classical cardiovascular risk factors. Diabetes Research and Clinical Practice 2005;68S1:S43–7.

Underwood PC dan Adler GK. The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans. Curent Hypertension Reports 2013;15:59–70.

Oak J dan Cai H. Attenuation of angiotensinII signaling recouples eNOS and inhibits nonendothelial NOx activity in diabetic mice. Diabetes 2007;56:118-26.

Rodrigues de Araujo G, Granato de Faria K, Lima WG, Bda CP, Rossoni JV, Souva AA, Chianca-Junior D, Silva ME, Pedrosa ML, Chaves MM, Costa DC. Effect of captopril and the bradykinin–PKC pathway on ROS production in type 1 diabetic rats. Canadian Journal of Physiology and Pharmacology 2011;89(12): 923-33.

Baluchnejadmojarad T, Roghani M, Imani A. Dose-dependent effect of captopril on aortic reactivity of streptozotocin-diabetic rats. Clinical and Experimental Pharmacology and Physiology 2004;31:342–7.

Zhang C, Hein TW, Wang W, Miller MW, Fossum TW, McDonald MM, Humphrey JD, Kuo L. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 2004;44:935–43.

Qiu XX, Li JM, Zhao J, Lin XF, Lou S, Jin KK, and Jiang XZ. The effects of ACEI on calpain-mediated cardiomyocytes apoptosis and cardiac function in diabetic rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2013;29(4):359-62.

Abd Allah ESH dan Gomaa AMS. Curcumin versus captopril on the functions of kidney and nerve in streptozotocin-induced diabetic rats: role of angiotensin-converting enzyme 1. Applied Physiology, Nutrition, and Metabolism 2015;40(10):1061-7.

Sharma JN dan Kesavarao U. The effects of captopril on cardiac regression, blood pressure and bradykinin components in diabetic Wistar Kyoto rats. International Journal of Immunopathology and Pharmacology 2011;24(2):337-43.

Baluchnejadmojarad, T., Roghani, M., and Imani, A. Dose-dependent effect of captopril on aortic reactivity of streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 2004;31:342–7.

Kabir AU, Samad MB, D’Costa NM, Akhter F, Ahmed A, and Hannan JMA. Anti-hyperglycemic activity of Centella asiatica is partly mediated by carbohydrase inhibition and glucose-fiber binding. BMC Complement Altern Med 2014;14:1-14.

Ghasemi A, Khalifi S, and Jedi S. Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review). Acta Physiol Hung 2014;101:408–20.

Institute for Animal Studies. Recommended Methods of Anesthesia, Analgesia, and Euthanasia for Labiratory Animal Species. New York: Albert Einstein College of Medicine 2014;1-12.

Zakaria EM, El-Bassossy HM, El-Maraghy NN, Ahmed AF, Ali AA. PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals. Eur J Pharmacol 2016;791:444–54.

Ti Y, Xie G, Wang Z, et al. Tribbles 3: A potential player in diabetic aortic remodelling. Diab Vasc Dis Res 2016.13:69–80.

Noda K, Hosoya M, Nakajima S, Ohashi J, Fukumoto Y, and Shimokawa H. Anti-Atherogenic Effects of the Combination Therapy with Olmesartan and Azelnidipine in Diabetic Apolipoprotein E-Deficient Mice. Tohoku J Exp Med 2012;228:305–15.

Sun H, Zhao Y, Bi X, et al. Valsartan blocks thrombospondin/transforming growth factor/Smads to inhibit aortic remodeling in diabetic rats. Diagn Pathol 2015;10:1-8.

Srivastava S, Ramana KV, Tammali R, Srivastava SK, and Bhatnagar A. Contribution of Aldose Reductase to Diabetic Hyperproliferation of Vascular Smooth Muscle Cells. Diabetes 2006;55:901–10.

Lin Y, Feng M, Lu CW, Lei YP, He ZM, and Xiong Y. Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits. Eur J Pharmacol 2017;798:43–48.

Fiordaliso F, Cuccovillo I, Bianchi R, et al. Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci 2006;79:121–9.

Abd Alla J, Langer A, Elzahwy SS, Arman-Kalcek G, Streichert T, and Quitterer U. Angiotensin-converting Enzyme Inhibition Down-regulates the Pro-atherogenic Chemokine Receptor 9 (CCR9)-Chemokine Ligand 25 (CCL25) Axis. J Biol Chem 2010;285:23496–505.

Adtani PN, Narasimhan M, Punnoose AM, and Kambalachenu HR. Antifibrotic effect of Centella asiatica Linn and asiatic acid on arecoline-induced fibrosis in human buccal fibroblasts. J Investig Clin Dent 2016;8:1-9.

Lu GX, Bian DF, Ji Y, et al. Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice by downregulating collagen deposition. Phytother Res PTR 2014;28:1224–31.

Pakdeechote P, Bunbupha S, Kukongviriyapan U, Prachaney P, Khrisanapant W, and Kukongviriyapan V. Asiatic Acid Alleviates Hemodynamic and Metabolic Alterations via Restoring eNOS/iNOS Expression, Oxidative Stress, and Inflammation in Diet-Induced Metabolic Syndrome Rats. Nutrients 2014;6:355–70.

Maneesai P, Bunbupha S, Kukongviriyapan U, et al. Asiatic acid attenuates renin-angiotensin system activation and improves vascular function in high-carbohydrate, high-fat diet fed rats. BMC Complement Altern Med 2016;16:1-11.

Faria AM, Papadimitriou A, Silva KC, Lopes de Faria JM and Lopes de Faria JB. Uncoupling Endothelial Nitric Oxide Synthase Is Ameliorated by Green Tea in Experimental Diabetes by Re-establishing Tetrahydrobiopterin Levels. Diabetes 2012;61:1838–47.

Satoh M. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. AJP Ren Physiol 2005;288:F1144– 52.

Wenzel P, Daiber A, Oelze M, et al. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis 2008;198:65–76.

Förstermann U and Münzel T. Endothelial Nitric Oxide Synthase in Vascular Disease. Circulation 2006;113:1708–14.

Fujisaka S, Usui I, Bukhari A, et al. Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice. Diabetes 2009;58:2574–82.

Martinez FO and Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Rep 2014;6:1-13.

Shen Z, Lu M, Duan S, and Duan S. Macrophage polarization and inflammation at the interface of cardiovascular disease and metabolism. NA J Med Sci 2011;4:191–5.

Miguel-Carrasco JL, Zambrano S, Blanca AJ, Mate A, and Vázquez CM. Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB. J Inflamm Lond Engl 2010;7:1-9.

Godsel LM, Leon JS, Wang K, Fornek JL, Molteni A, and Engman DM. Captopril prevents experimental autoimmune myocarditis. J Immunol Baltim Md 2003;171:346–52.

Bian GX, Li GG, Yang Y, et al. Madecassoside reduces ischemia-reperfusion injury on regional ischemia induced heart infarction in rat. Biol Pharm Bull 2008;31:458–63.

Yun KJ, Kim JY, Kim JB, et al. Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-κB inactivation in RAW 264.7 macrophages: Possible involvement of the IKK and MAPK pathways. Int Immunopharmacol 2008;8:431–41.


Refbacks

  • There are currently no refbacks.